Recurrent Small Lymphocytic Lymphoma [clinicaltrials_resource:3d80ccbc7fce84aff0f253b964c3b574]
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003210]Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00003970]17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [clinicaltrials:NCT00004241]Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [clinicaltrials:NCT00005786]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma [clinicaltrials:NCT00005950]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer [clinicaltrials:NCT00006251]Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00006473]Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00009984]Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00010192]clinicaltrials:NCT00012298Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT00014235]Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00017381]Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia [clinicaltrials:NCT00017472]Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [clinicaltrials:NCT00019708]Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00022581]Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [clinicaltrials:NCT00025415]Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00026182]Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies [clinicaltrials:NCT00040846]clinicaltrials:NCT00049504Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction [clinicaltrials:NCT00054483]clinicaltrials:NCT00054639Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma [clinicaltrials:NCT00058227]Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma [clinicaltrials:NCT00058240]Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [clinicaltrials:NCT00058305]Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma [clinicaltrials:NCT00060112]Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia [clinicaltrials:NCT00060424]Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00068315]Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies [clinicaltrials:NCT00072514]Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma [clinicaltrials:NCT00077155]Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT00078858]Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [clinicaltrials:NCT00079378]FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00079443]clinicaltrials:NCT00082888Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [clinicaltrials:NCT00089154]17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [clinicaltrials:NCT00089271]Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT00096005]
condition [clinicaltrials_vocabulary:condition]
Recurrent Small Lymphocytic Lymphoma [clinicaltrials_resource:3d80ccbc7fce84aff0f253b964c3b574]
Bio2RDF identifier
3d80ccbc7fce84aff0f253b964c3b574
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3d80ccbc7fce84aff0f253b964c3b574
identifier
clinicaltrials_resource:3d80ccbc7fce84aff0f253b964c3b574
title
Recurrent Small Lymphocytic Lymphoma
@en
label
Recurrent Small Lymphocytic Ly ...... 0ccbc7fce84aff0f253b964c3b574]
@en